Regulating Direct-to-Consumer Polygenic Risk Scores

Jacob S Sherkow^{1

2}, Jin K Park³, Christine Y Lu^{3

4}

Affiliations

¹ College of Law, University of Illinois at Urbana-Champaign, Champaign.
² Carle Illinois College of Medicine, University of Illinois at Urbana-Champaign, Urbana.
³ Harvard Medical School, Harvard University, Boston, Massachusetts.
⁴ Pharmacy School, University of Sydney, Sydney, New South Wales, Australia.

Jacob S Sherkow et al. JAMA. 2023.

. 2023 Aug 22;330(8):691-692.

doi: 10.1001/jama.2023.12262.

Jacob S Sherkow^{1

2}, Jin K Park³, Christine Y Lu^{3

4}

¹ College of Law, University of Illinois at Urbana-Champaign, Champaign.
² Carle Illinois College of Medicine, University of Illinois at Urbana-Champaign, Urbana.
³ Harvard Medical School, Harvard University, Boston, Massachusetts.
⁴ Pharmacy School, University of Sydney, Sydney, New South Wales, Australia.

No abstract available

Plain language summary

This Viewpoint discusses the possible harms associated with direct-to-consumer polygenic risk scores and advocates for federal regulation.